Latest Breaking News On - Guido torzilli - Page 1 : comparemela.com

Patient-specific organ-on-chip aims to accelerate research on cholangiocarcinoma

It is only a few centimeters in size and can be held between two fingers, but in the micro-channels carved inside it, it's hidden a three-dimensional and highly faithful model of a biliary tract cancer called cholangiocarcinoma, complete with its tumor microenvironment.

Istituto clinico humanitasMarco rasponiGuido torzilliBiomimetic microsystemsHumanitas universityItalian foundation for cancer researchHepatobiliary immunopathology laboratory at humanitas research hospitalLaboratory of microfluidicsAna lleo de naldaHepatobiliary immunopathology laboratoryHumanitas research hospitalGeneral surgeryHepatobiliary surgery unitAna lleoItalian foundationCancer research

Organ-on-Chip Accelerates Cholangiocarcinoma Research, Personalized Care

Organ-on-Chip Accelerates Cholangiocarcinoma Research, Personalized Care
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Istituto clinico humanitasMarco rasponiGuido torzilliBiomimetic microsystemsLaboratory of microfluidicsItalian foundation for cancer researchHepatobiliary immunopathology laboratory at humanitas research hospitalHumanitas universityAna lleo de naldaHepatobiliary immunopathology laboratoryHumanitas research hospitalGeneral surgeryHepatobiliary surgery unitAna lleoItalian foundationCancer research

Cholangiocarcinoma: New organ-on-chip aims at accelerating research and personalized medicine

Cholangiocarcinoma: New organ-on-chip aims at accelerating research and personalized medicine
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Biomimetic microsystemsIstituto clinico humanitasMarco rasponiGuido torzilliMichela anna polidoroLaboratory of microfluidicsHepatobiliary immunopathology laboratory at humanitas research hospitalHumanitas universityAna lleo de naldaHepatobiliary immunopathology laboratoryHumanitas research hospitalGeneral surgeryHepatobiliary surgery unit

HistoSonics Receives Approval To Begin European #HOPE4LIVER Clinical Study

HistoSonics Receives Approval To Begin European #HOPE4LIVER Clinical Study Company Now Cleared to Use Its Novel Sonic Beam Therapy in Dual U.S. and European Studies News provided by Share this article Share this article MINNEAPOLIS, Jan. 11, 2021 /PRNewswire/ HistoSonics, developer of a non-invasive platform and novel sonic beam therapy, announced today that it has received approval to initiate the company s second European clinical trial of its new platform technology, which is designed to use the science of histotripsy to mechanically destroy targeted liver tumors, from outside of the body. The study, similar to HistoSonics recent FDA approved #HOPE4LIVER U.S. Study, is a multi-center, open label, single arm trial to evaluate the safety and efficacy in destroying liver tumors and will build upon the company s first-in-man THERESA Study recently conducted in Barcelona, Spain. The company expects to begin enrolling patients in early 2021.

Ann arborUnited statesComunidad autonoma de catalunaGuido torzilliJoe amaralLuigi solbiatiPrnewswire histosonicsHistosonics incHumanitas research hospitalPrincipal investigatorHistosonic vice presidentMedical affairsPrincipal investigatorsஆண்டு ஆர்பர்ஒன்றுபட்டது மாநிலங்களில்காமுனிடட தன்னாட்சி டி கடலுள்